Danaher Corporation (NYSE:DHR) Shares Acquired by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd increased its stake in Danaher Corporation (NYSE:DHR) by 3,673.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 38,037 shares of the conglomerate’s stock after buying an additional 37,029 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Danaher were worth $7,812,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. Fortis Capital Advisors LLC grew its stake in shares of Danaher by 1.3% in the fourth quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock valued at $914,000 after buying an additional 50 shares in the last quarter. Fayez Sarofim & Co grew its stake in shares of Danaher by 0.6% in the fourth quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate’s stock valued at $1,902,000 after buying an additional 50 shares in the last quarter. Coastal Bridge Advisors LLC grew its stake in shares of Danaher by 4.8% in the fourth quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate’s stock valued at $252,000 after buying an additional 50 shares in the last quarter. Perennial Investment Advisors LLC grew its stake in shares of Danaher by 2.2% in the fourth quarter. Perennial Investment Advisors LLC now owns 2,343 shares of the conglomerate’s stock valued at $538,000 after buying an additional 51 shares in the last quarter. Finally, MGO One Seven LLC grew its stake in Danaher by 1.3% during the 4th quarter. MGO One Seven LLC now owns 4,285 shares of the conglomerate’s stock valued at $984,000 after purchasing an additional 53 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 0.0%

Shares of NYSE DHR opened at $197.08 on Friday. The company has a market cap of $141.12 billion, a price-to-earnings ratio of 41.93, a price-to-earnings-growth ratio of 2.74 and a beta of 0.73. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock’s 50 day simple moving average is $197.49 and its 200 day simple moving average is $202.68.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The business’s revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the business posted $1.72 EPS. Equities research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 25th. Shareholders of record on Friday, June 27th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is currently 27.23%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Wolfe Research lowered their price objective on Danaher from $275.00 to $220.00 and set an “outperform” rating for the company in a research note on Monday, April 7th. Bank of America lowered their price objective on Danaher from $265.00 to $230.00 in a research note on Monday, April 14th. Citigroup reiterated a “buy” rating on shares of Danaher in a research report on Monday, April 7th. Jefferies Financial Group decreased their target price on Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Finally, Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a research report on Friday, July 11th. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average target price of $247.61.

Insiders Place Their Bets

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman owned 3,105,808 shares of the company’s stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.